Cardiovascular effects of intravenously given ATP-MgCl2 in canine hemorrhagic shock

Area of Science:

• Cardiovascular Physiology
• Cellular Metabolism
• Biochemistry

Background:

• Adenosine triphosphate (ATP) plays a crucial role in cellular energy metabolism.
• ATP-MgCl2 complex is sometimes used in research or clinical settings.
• Understanding the effects of exogenous ATP on cardiac function is important.

Purpose of the Study:

• To investigate the effects of intravenous ATP-MgCl2 complex on cardiac performance in dogs.
• To determine if ATP-MgCl2 administration impacts myocardial oxygen delivery and utilization.
• To identify potential cellular mechanisms underlying observed changes in cardiac function.

Main Methods:

• Dogs were administered either lactated Ringer's solution alone or lactated Ringer's solution plus intravenous ATP-MgCl2 complex.
• Hemodynamic parameters including mean arterial blood pressure, cardiac output, stroke volume, and left ventricular pressure rise were measured.
• Myocardial oxygen delivery, extraction, and lactate balance were assessed.

Main Results:

• Dogs receiving ATP-MgCl2 showed significantly lower mean arterial blood pressure, cardiac output, stroke volume, and rate of left ventricular pressure rise compared to controls.
• Reduced cardiac performance occurred even with adequate coronary blood flow and myocardial oxygen delivery.
• A decrease in myocardial oxygen extraction and a negative myocardial lactate balance were observed in the ATP-MgCl2 group.

Conclusions:

• Intravenous administration of ATP-MgCl2 complex impairs cardiac performance in dogs.
• The impairment appears to stem from a cellular metabolic defect rather than compromised oxygen supply.
• Further research is warranted to elucidate the precise mechanisms of ATP-induced cardiac dysfunction.